Who’s Who: Fars bin Kaed Alanazi, CEO of the Saudi National Institute for Health

Fars bin Kaed Alanazi
Fars bin Kaed Alanazi
Short Url
Updated 18 September 2022
Follow

Who’s Who: Fars bin Kaed Alanazi, CEO of the Saudi National Institute for Health

Fars bin Kaed Alanazi

Fars bin Kaed Alanazi is the CEO of the Saudi National Institute for Health. It is one of the Kingdom’s health transformation initiative programs and is the main supporter of health translational research and clinical trials which contributes to ensuring the quality, well-being, and excellence of national health research outputs.

Alanazi had his Pharm. B. in pharmacy from King Saud University, and a doctorate from the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia.

He began his career as an assistant professor in the Department of Pharmaceutics at the College of Pharmacy at King Saud University in 2004.

After that, he served as head of the coordination office of The Custodian of the Two Holy Mosques Scholarship Program at the Ministry of Education in 2005 as the first building block of this program. Then he worked as the head of the pharmaceutics department at King Saud University.

In addition, he continued his professional journey to become the VP assistant for technology transfer and knowledge exchange at King Saud University in 2006.

Subsequently, he chaired the master of quality in pharmacy program at the College of Pharmacy at King Saud University in 2018.

He oversaw the scientific chair of Dr. Walid Al-Kayali for pharmaceutical industry since 2007 till today.

Alanazi currently heads as the CEO of the Saudi National Institute for Health to contribute to the development of the Kingdom’s research and innovative health potential.

He has authored 10 books and contributed to several others chapters. He has also published more than 200 papers granted 14 patents from patent offices of the US, Europe, and Saudi Arabia.

He supervised 37 doctoral and master’s students in Saudi Arabian, Arab and international universities. He has been awarded and received medals of excellence in research and innovation.

In 2018, Alanazi won the Lifetime Achievement Award from King Saud University. He was honored by the Ministry of Higher Education and other academic institutions, and received a silver medal at the Geneva Inventions from the International Inventions Salon in 2014, and the Best Research Chair Award from King Saud University in 2012.

He is also a member in several national and international committees and has received honorary and professional memberships from the Saudi Pharmaceutical Society, and the American Association of Pharmaceutical Scientists.